NEW YORK (GenomeWeb News) – Ingenuity Systems today said that it has partnered with Covance Genomics on next-generation sequencing data analysis.
Under the collaboration, the firms intend to develop new approaches using Ingenuity's IPA software to "obtain more actionable insights from NGS data and to answer research questions in a relevant biological context."
Covance Genomics Laboratory is part of clinical research services firm Covance and provides genomics-based drug discovery and development work for clients. Among the tools it uses are Illumina sequencers and array platforms from Agilent and Affymetrix.
"We're confident the combination of our best-in-class genomics data and the high-quality biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers," Tom Turi, VP of science and technology for Covance Discovery & Translational Services, said in a statement.
Financial and other terms of the alliance were not disclosed.